| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 02/23/2005 | CN1190488C Culture pond process of producing photosythetic bacteria for animal and plant |
| 02/23/2005 | CN1190487C Edible'Linggu'fungus series |
| 02/22/2005 | US6858721 Method for producing cytosine nucleoside compounds |
| 02/22/2005 | US6858716 Drosophila recombination-associated protein and methods for use |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
| 02/22/2005 | US6858704 Oligopeptide sequences with c-terminal acidic tails (ATS); increased stability in enzymes, foods, medicines and chemical products |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858430 Preparing sea water aquaculture of phaeophytic marine alga for generating bioreactor for expression of heterologous polypeptides |
| 02/22/2005 | US6858429 Universal light-switchable gene promoter system |
| 02/22/2005 | US6858424 Apparatus for use in the storage and preservation of pharmaceutical and biological materials |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858417 Dna fragment carrying toluene monooxygenase, gene, recombinant plasmid, transformed microorganism, method for degrading chlorinated aliphatic hydrocarbon compounds and aromatic compounds, and method for environmental remediation |
| 02/22/2005 | US6858416 Human desaturase gene and uses thereof |
| 02/22/2005 | US6858411 Recombinant nucleic acids that encode epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells to produce epothilone derivatives/polyketides; used as cancer drugs, fungicides and immunosuppressants |
| 02/22/2005 | US6858410 Process for making antifusogenic fusion peptides that form inclusion bodies |
| 02/22/2005 | US6858408 Genetically engineered expression vector coding enzymatic polypeptide for use in laundering detergents, textile treatment and paper processing |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858406 Process for the microbial production of amino acids by boosted activity of export carriers |
| 02/22/2005 | US6858404 Genes for the biosynthesis of epothilones |
| 02/22/2005 | US6858382 Detection systems for registering protein interactions and functional relationships |
| 02/22/2005 | US6858213 Mycobacterial sulfation pathway proteins and methods of use thereof |
| 02/22/2005 | US6858212 Water-soluble yeast extract produced by adding peroxide to growing yeast cells |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/22/2005 | US6858207 Methods and materials relating to novel CD39-like polypeptides |
| 02/22/2005 | CA2185352C Novel muteins of ifn-.beta. |
| 02/17/2005 | WO2005014848A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 02/17/2005 | WO2005014845A1 Application of cloud point system in biological transforming |
| 02/17/2005 | WO2005014823A2 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 02/17/2005 | WO2005014809A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 02/17/2005 | WO2005014805A1 A structured material for the production of hydrogen |
| 02/17/2005 | WO2005014790A2 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same |
| 02/17/2005 | WO2005014654A2 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | WO2005014570A1 CELLS AND METHOD FOR THE FERMENTATIVE PRODUCTION OF R-α-LIPOIC ACID |
| 02/17/2005 | WO2005013680A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 02/17/2005 | WO2004101803A3 Process for producing anticancer agent ll-d45042 |
| 02/17/2005 | WO2004090118A8 Lactobacillus plantarum strain st-iii and its use in adjusting blood fat |
| 02/17/2005 | WO2004047740A3 Composition and method for treating lupus nephritis |
| 02/17/2005 | WO2004044126A3 Novel proteins and their uses |
| 02/17/2005 | WO2004033471A3 Glucose transport mutants for production of biomaterial |
| 02/17/2005 | WO2003104412A3 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects |
| 02/17/2005 | WO2003091431A8 Methylotroph producing mammalian type sugar chain |
| 02/17/2005 | WO2003082019A9 Peptides with anti-hypertensive properties |
| 02/17/2005 | WO2003070187A3 Fusion proteins of mycobacterium tuberculosis |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002101013A3 A biological method for the production of alpha-methylene-gamma-butyrolactone and its intermediates |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050039232 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses |
| 02/17/2005 | US20050039224 Producing forced open regulatory nucleotide sequence complex for use as tool in conntrolling heterologous gene expression in transfected cells |
| 02/17/2005 | US20050038610 Apparatus and method for automated protein design |
| 02/17/2005 | US20050038255 Stereoselective preparation of cyclic l-amino acids |
| 02/17/2005 | US20050038254 Efficient incubation preparation of such as terfenadine carboxylic acid metabolite |
| 02/17/2005 | US20050038232 Monoclonal antibody for use in detection and screening for biological warfare agents |
| 02/17/2005 | US20050038228 Makes it possible to selectively adsorb an immunoglobulin and/or an immune complex present in a body fluid (for example, blood, plasma, etc.) efficiently without pretreating the body fluid |
| 02/17/2005 | US20050038086 Epothilone derivatives and methods for making and using the same |
| 02/17/2005 | US20050037955 Bactericides; fungicides; isolated polypeptides; inflammatory bowel disorders; infections |
| 02/17/2005 | US20050037480 Using high-nitrogen nutrient broth to propagate cyanobacterium; edible microorganisms and dairy products |
| 02/17/2005 | US20050037473 transformed E. coli comprises a polyhydroxyalkanoate (PHA) synthase gene of Pseudomonas species; producing PHA using a microorganism transformed with a recombinant vector containing the maoC gene and a recombinant vector containing a PHA synthase gene |
| 02/17/2005 | US20050037470 Method of preparing a guanosine-group compound and an intermediate thereof |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037459 Variant humicola grisea CBH1.1 |
| 02/17/2005 | US20050037456 Purification of polypeptides |
| 02/17/2005 | US20050037453 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037385 Genetically engineered protein comprising multiple zinc finger domains for use as regulatory quadruplets in gene expression analysis |
| 02/17/2005 | US20050037376 Sulfatase polypeptide for use in treatment and prevention of microbial infection, cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/17/2005 | US20050037375 Using ligand-receptor interactions as tool to monitor effectiveness of modulators in disease treatment which act via receptor binding; drug screening and design |
| 02/17/2005 | US20050037345 Gene with polynucleopotide codes with polypeptide with amino acid sequences for domains and molecular hybridization for gene expression and cancer |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037333 Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures |
| 02/17/2005 | US20050037005 5c8 Antigen |
| 02/17/2005 | US20050036990 Bacillus megaterium for degradation of fats, oils and grease; bioavailability |
| 02/17/2005 | US20050036987 Suicide gene-containing strains of bacteria, fungi, and protists; tumor specific shigella species |
| 02/17/2005 | DE10331291A1 Varianten der 3-Phosphoglyceratdehydrogenase mit reduzierter Hemmung durch L-Serin und dafür codierende Gene Variants of the 3-phosphoglycerate dehydrogenase with reduced inhibition by L-serine, and genes coding therefor |
| 02/17/2005 | DE10328552A1 Producing defined enzyme mixture and/or metabolite mixture for fermentation of target substrates, by inoculating microorganisms in solid-phase bioreactor with inducer substrates and keeping mixed culture under appropriate conditions |
| 02/17/2005 | CA2555323A1 Polypeptide specific to liver cancer, polynucleotide coding for the polypeptide, and rna molecule suppressing expression of the polypeptide |
| 02/17/2005 | CA2535517A1 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | CA2534708A1 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 02/17/2005 | CA2531314A1 Method to improve the taste of food or beverage with a reduced amount of total fat by addition of yeast extract and food or beverage thereof |
| 02/17/2005 | CA2530497A1 Improved electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 02/16/2005 | EP1507008A2 Nucleotide sequences which code for the sahH gene |
| 02/16/2005 | EP1507007A1 Cell cycle related proteins |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1507000A2 A thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 02/16/2005 | EP1506996A2 Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
| 02/16/2005 | EP1506995A1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506309A2 Plating media |
| 02/16/2005 | EP1506306A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 02/16/2005 | EP1506305A2 Dna and amino acid sequences of a tyrosine-inducible tyrosine ammonia lyase enzyme from the yeast trichosporon cutaneum |
| 02/16/2005 | EP1506302A2 Non-revertible beta-oxidation blocked candida tropicalis |
| 02/16/2005 | EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 02/16/2005 | EP1506297A2 Brachyspira hyodysenteriae vaccine |
| 02/16/2005 | EP1506294A1 Hydantoin racemase |
| 02/16/2005 | EP1506293A2 Microbial conversion of glucose to para-hydroxystyrene |
| 02/16/2005 | EP1506292A1 Pectate lyase variants |
| 02/16/2005 | EP1506291A2 Novel phospholipases and uses thereof |
| 02/16/2005 | EP1506288A2 Activation induced deaminase (aid) |
| 02/16/2005 | EP1506286A2 Neutralizing human anti-igfr antibody |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |